EOL-02 - (Expert Opinion Live) How A Novel Office Dispensed Transdermal Cannabinoid Cream Improved QOL For Over 90% Of My Patients & Generated Six Figure Annual Profits

This presentation will include a brief overview of cannabinoid types, clinical and scientific literature summaries, emerging technologies within the industry, current regulations and the potential financial impact for direct-to-patient dispensing of the Tolcylen Transdermal CBD/CBG Cream. Dr DiNucci will also discuss the key differences and how to choose products for your patients and review a six-figure net profit summary generated from his solo practice yearly dispensing data.

This session is sponsored by Marlinz Pharma. This session is not certified for credit.